SCHEMBL7400380

SCHEMBL7400380

Clc1ccc(N2CCN(CCC3OCCc4cc(Br)ccc43)CC2)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.53
HTR2A P28223 7/20 0.53
DRD4 P21917 6/20 0.53
HTR1A P08908 5/20 0.53
ADRA2A P08913 1/20 0.53
ADRA2B P18089 1/20 0.53
ADRA2C P18825 1/20 0.53
DRD1 P21728 1/20 0.53
ADRA1D P25100 1/20 0.53
ADRA1A P35348 1/20 0.53
ADRA1B P35368 1/20 0.53
DRD3 P35462 1/20 0.53
HTR2B P41595 1/20 0.53
HTR1D P28221 9/20 0.52
SLC6A4 P31645 1/20 0.52
HTR1B P28222 2/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA4 P22748 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7400313 0.90 DRD2 (0.58) DRD2HTR2ADRD4HTR1AADRA2A
SCHEMBL8592601 0.89 DRD2 (0.56) DRD2HTR2ADRD4HTR1AADRA2A
SCHEMBL7407993 0.86 DRD2 (0.71) DRD2HTR2ADRD4HTR1AADRA2A
SCHEMBL7398234 0.85 DRD2 (0.73) DRD2HTR2ADRD4HTR1AADRA2A
SCHEMBL7398929 0.85 DRD2 (0.58) DRD2HTR2ADRD4HTR1AADRA2A
Hydrochloric Acid SCHEMBL7405500 0.85 DRD2 (0.70) DRD2HTR2ADRD4HTR1AADRA2A
SCHEMBL7401245 0.84 HTR1D (0.73) DRD2HTR2ADRD4HTR1AHTR1D
SCHEMBL8591378 0.84 HTR1D (0.56) DRD2HTR2ADRD4HTR1AADRA2A
SCHEMBL8591372 0.84 HTR1D (0.56) DRD2HTR2ADRD4HTR1AADRA2A
SCHEMBL7403729 0.83 DRD2 (0.74) DRD2HTR2ADRD4HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP claimed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP claimed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO claimed
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
US-5877317-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 1999-03-02 US disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed